Skip to main content
Erschienen in: Osteoporosis International 8/2007

01.08.2007 | Original Article

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women

verfasst von: J. A. Kanis, A. Oden, O. Johnell, H. Johansson, C. De Laet, J. Brown, P. Burckhardt, C. Cooper, C. Christiansen, S. Cummings, J. A. Eisman, S. Fujiwara, C. Glüer, D. Goltzman, D. Hans, M.-A. Krieg, A. La Croix, E. McCloskey, D. Mellstrom, L. J. Melton III, H. Pols, J. Reeve, K. Sanders, A-M. Schott, A. Silman, D. Torgerson, T. van Staa, N. B. Watts, N. Yoshimura

Erschienen in: Osteoporosis International | Ausgabe 8/2007

Einloggen, um Zugang zu erhalten

Abstract

Summary

BMD and clinical risk factors predict hip and other osteoporotic fractures. The combination of clinical risk factors and BMD provide higher specificity and sensitivity than either alone.

Introduction and hypotheses

To develop a risk assessment tool based on clinical risk factors (CRFs) with and without BMD.

Methods

Nine population-based studies were studied in which BMD and CRFs were documented at baseline. Poisson regression models were developed for hip fracture and other osteoporotic fractures, with and without hip BMD. Fracture risk was expressed as gradient of risk (GR, risk ratio/SD change in risk score).

Results

CRFs alone predicted hip fracture with a GR of 2.1/SD at the age of 50 years and decreased with age. The use of BMD alone provided a higher GR (3.7/SD), and was improved further with the combined use of CRFs and BMD (4.2/SD). For other osteoporotic fractures, the GRs were lower than for hip fracture. The GR with CRFs alone was 1.4/SD at the age of 50 years, similar to that provided by BMD (GR = 1.4/SD) and was not markedly increased by the combination (GR = 1.4/SD). The performance characteristics of clinical risk factors with and without BMD were validated in eleven independent population-based cohorts.

Conclusions

The models developed provide the basis for the integrated use of validated clinical risk factors in men and women to aid in fracture risk prediction.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137–1141PubMed Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137–1141PubMed
2.
Zurück zum Zitat Committee for Proprietary Medicinal Products (CPMP) (2001) Note for guidance on postmenopausal osteoporosis in women. European Agency for the Evaluation of Medicinal Products, London (CPMP/EWP/552/95 rev 1) Committee for Proprietary Medicinal Products (CPMP) (2001) Note for guidance on postmenopausal osteoporosis in women. European Agency for the Evaluation of Medicinal Products, London (CPMP/EWP/552/95 rev 1)
3.
Zurück zum Zitat Food and Drug Administration (1994) Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. Division of Metabolism and Endocrine Drug Products, Rockville, MD Food and Drug Administration (1994) Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. Division of Metabolism and Endocrine Drug Products, Rockville, MD
4.
Zurück zum Zitat Royal College of Physicians (1999) Clinical Guidelines for strategies to prevent and treat osteoporosis. Royal College of Physicians, London Royal College of Physicians (1999) Clinical Guidelines for strategies to prevent and treat osteoporosis. Royal College of Physicians, London
5.
Zurück zum Zitat Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D, on behalf of the European Foundation for Osteoporosis and Bone Disease (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporosis Int 7:390–406CrossRef Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D, on behalf of the European Foundation for Osteoporosis and Bone Disease (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporosis Int 7:390–406CrossRef
6.
Zurück zum Zitat National Osteoporosis Foundation (NOF) (2003) Physician’s Guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC National Osteoporosis Foundation (NOF) (2003) Physician’s Guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC
7.
Zurück zum Zitat European Community (1998) Report on osteoporosis in the European Community. EC, Strasbourg European Community (1998) Report on osteoporosis in the European Community. EC, Strasbourg
8.
Zurück zum Zitat Brown JP, Josse RG (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J 167(10 Suppl):S1–S34 Brown JP, Josse RG (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J 167(10 Suppl):S1–S34
9.
Zurück zum Zitat Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929–1936PubMedCrossRef Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929–1936PubMedCrossRef
10.
Zurück zum Zitat De Laet C, Oden A, Johansson H, Johnell O, Jonsson B, Kanis JA (2005) The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 16:313–318PubMedCrossRef De Laet C, Oden A, Johansson H, Johnell O, Jonsson B, Kanis JA (2005) The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 16:313–318PubMedCrossRef
11.
Zurück zum Zitat Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Eisman J, McCloskey EV, Mellstrom D, Melton LJ III, Pols H, Reeve J, Silman AJ, Tenenhouse A (2004) A family history of fracture and fracture risk. Bone 35:1029–1037PubMedCrossRef Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Eisman J, McCloskey EV, Mellstrom D, Melton LJ III, Pols H, Reeve J, Silman AJ, Tenenhouse A (2004) A family history of fracture and fracture risk. Bone 35:1029–1037PubMedCrossRef
12.
Zurück zum Zitat Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Melton LJ, Tenenhouse A, Reeve J, Silman AJ, Pols HAP, Eisman JA, McCloskey EV, Mellstrom D (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893–899PubMedCrossRef Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Melton LJ, Tenenhouse A, Reeve J, Silman AJ, Pols HAP, Eisman JA, McCloskey EV, Mellstrom D (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893–899PubMedCrossRef
13.
Zurück zum Zitat Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton III LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382PubMedCrossRef Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton III LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382PubMedCrossRef
14.
Zurück zum Zitat Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier P, Melton LJ III, O’Neill T, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Predictive value of bone mineral density for hip and other fractures. J Bone Miner Res 20:1185–1194PubMedCrossRef Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier P, Melton LJ III, O’Neill T, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Predictive value of bone mineral density for hip and other fractures. J Bone Miner Res 20:1185–1194PubMedCrossRef
15.
Zurück zum Zitat De Laet C, Kanis JA, Oden A (2005) Body mass index as a prediction of fracture risk. A meta-analysis. Osteoporos Int, in press De Laet C, Kanis JA, Oden A (2005) Body mass index as a prediction of fracture risk. A meta-analysis. Osteoporos Int, in press
16.
Zurück zum Zitat Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman A, Pols H, Tenenhouse A (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742PubMedCrossRef Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman A, Pols H, Tenenhouse A (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742PubMedCrossRef
17.
Zurück zum Zitat Kanis JA, Johansson H, Oden A, De Laet C, Johnell O, Eisman JA, McCloskey E, Mellstrom D, Pols H, Reeve J, Silman A, Tenenhouse A (2005) A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporos Int, in press Kanis JA, Johansson H, Oden A, De Laet C, Johnell O, Eisman JA, McCloskey E, Mellstrom D, Pols H, Reeve J, Silman A, Tenenhouse A (2005) A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporos Int, in press
18.
Zurück zum Zitat Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D, Melton LJ III, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:222–228PubMedCrossRef Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D, Melton LJ III, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:222–228PubMedCrossRef
19.
Zurück zum Zitat Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporos Int 16:581–589PubMedCrossRef Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporos Int 16:581–589PubMedCrossRef
20.
Zurück zum Zitat Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA (1991) Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 7:403–422PubMedCrossRef Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA (1991) Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 7:403–422PubMedCrossRef
21.
Zurück zum Zitat De Laet CEDH, Van Hout BA, Burger H, Hofman A, Weel AEAM, Pols HAP (1998) Hip fracture prediction in elderly men and women: validation of the Rotterdam Study. J Bone Miner Res 13:1587–1593PubMedCrossRef De Laet CEDH, Van Hout BA, Burger H, Hofman A, Weel AEAM, Pols HAP (1998) Hip fracture prediction in elderly men and women: validation of the Rotterdam Study. J Bone Miner Res 13:1587–1593PubMedCrossRef
22.
Zurück zum Zitat O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010–1017PubMedCrossRef O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010–1017PubMedCrossRef
23.
Zurück zum Zitat Felsenberg D, Silman AJ, Lunt M, Ambrecht G, Ismail AA, Finn JD, Cockerill WC, Banzer D, Benevolenskaya LI, Bhalla A, Bruges Armas J, Cannata JB, Cooper C, Dequeker J, Eastell R, Ershova O, Felsch B, Gowin W, Havelka S, Hoszowski K, Jajic I, Janot J, Johnell O, Kanis JA, Kragl G, Lopez Vaz A, Lorenc R, Lyritis G, Masaryk P, Matthis C, Miazgowski T, Parisi G, Pols HAP, Poor G, Raspe HH, Reid DM, Reisinger W, Scheidt-Nave C, Stepan J, Todd C, Weber K, Woolf AD, Reeve J, O’Neill TW (2002) Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study Epos. J Bone Miner Res 17:716–724CrossRef Felsenberg D, Silman AJ, Lunt M, Ambrecht G, Ismail AA, Finn JD, Cockerill WC, Banzer D, Benevolenskaya LI, Bhalla A, Bruges Armas J, Cannata JB, Cooper C, Dequeker J, Eastell R, Ershova O, Felsch B, Gowin W, Havelka S, Hoszowski K, Jajic I, Janot J, Johnell O, Kanis JA, Kragl G, Lopez Vaz A, Lorenc R, Lyritis G, Masaryk P, Matthis C, Miazgowski T, Parisi G, Pols HAP, Poor G, Raspe HH, Reid DM, Reisinger W, Scheidt-Nave C, Stepan J, Todd C, Weber K, Woolf AD, Reeve J, O’Neill TW (2002) Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study Epos. J Bone Miner Res 17:716–724CrossRef
24.
Zurück zum Zitat Ismail AA, Pye SR, Cockerill WC, Lunt M, Silman AJ, Reeve J, Banzer D, Benevolenskaya LI, Bhalla A, Bruges Armas J, Cannata JB, Cooper C, Delmas PD, Dequeker J, Dilsen G, Falch JA, Felsch B, Felsenberg D, Finn JD, Gennari C, Hoszowski K, Jajic I, Janott J, Johnell O, Kanis JA, Kragl G, Lopez Vaz A, Lorenc R, Lyritis G, Marchand F, Masaryk P, Matthis C, Miazgowski T, Naves-Diaz M, Pols HAP, Poor G, Rapado A, Raspe HH, Reid DM, Reisinger W, Scheidt-Nave C, Stepan J, Todd C, Weber K, Woolf AD, O’Neill TW (2002) Incidence of limb fracture across Europe: results from the European prospective osteoporosis study, EPOS. Osteoporosis Int 13:565–571CrossRef Ismail AA, Pye SR, Cockerill WC, Lunt M, Silman AJ, Reeve J, Banzer D, Benevolenskaya LI, Bhalla A, Bruges Armas J, Cannata JB, Cooper C, Delmas PD, Dequeker J, Dilsen G, Falch JA, Felsch B, Felsenberg D, Finn JD, Gennari C, Hoszowski K, Jajic I, Janott J, Johnell O, Kanis JA, Kragl G, Lopez Vaz A, Lorenc R, Lyritis G, Marchand F, Masaryk P, Matthis C, Miazgowski T, Naves-Diaz M, Pols HAP, Poor G, Rapado A, Raspe HH, Reid DM, Reisinger W, Scheidt-Nave C, Stepan J, Todd C, Weber K, Woolf AD, O’Neill TW (2002) Incidence of limb fracture across Europe: results from the European prospective osteoporosis study, EPOS. Osteoporosis Int 13:565–571CrossRef
25.
Zurück zum Zitat Kreiger N, Tenenhouse A, Joseph L et al (1999) The canadian multicentre osteoporosis study CaMos: background, rationale, methods. Can J Ageing 18:376–387 Kreiger N, Tenenhouse A, Joseph L et al (1999) The canadian multicentre osteoporosis study CaMos: background, rationale, methods. Can J Ageing 18:376–387
26.
Zurück zum Zitat Melton LJ III, Crowson CS, O’Fallon WM, Wahner HW, Riggs BL (2003) Relative contributions of bone density, bone turnover and clinical risk factors to long-term fracture prediction. J Bone Miner Res 18:312–318PubMedCrossRef Melton LJ III, Crowson CS, O’Fallon WM, Wahner HW, Riggs BL (2003) Relative contributions of bone density, bone turnover and clinical risk factors to long-term fracture prediction. J Bone Miner Res 18:312–318PubMedCrossRef
27.
Zurück zum Zitat Melton LJ III, Atkinson EJ, O’Connor MK, O’Fallon WM, Riggs BL (1998) Bone density and fracture risk in men. J Bone Miner Res 13:1915–1923PubMedCrossRef Melton LJ III, Atkinson EJ, O’Connor MK, O’Fallon WM, Riggs BL (1998) Bone density and fracture risk in men. J Bone Miner Res 13:1915–1923PubMedCrossRef
28.
Zurück zum Zitat Johansson H, Oden A, Johnell O, Jonsson B, De Laet C, Oglesby A, McCloskey EV, Kayan K, Jalava T, Kanis JA (2004) Optimisation of BMD measurements to identify high risk groups for treatment-A test analysis. J Bone Miner Res 19:906–913PubMedCrossRef Johansson H, Oden A, Johnell O, Jonsson B, De Laet C, Oglesby A, McCloskey EV, Kayan K, Jalava T, Kanis JA (2004) Optimisation of BMD measurements to identify high risk groups for treatment-A test analysis. J Bone Miner Res 19:906–913PubMedCrossRef
29.
Zurück zum Zitat McCloskey EV, Beneton M, Charlesworth D, Kayan K, Detakats D, Dey A, OrgeeJ, Ashford R, Forster M, Cliffe J, Kersh L, Brazier J, Nichol J, Aropuu S, Jalava T, Kanis JA (2006) Clodronate reduces the incidence of fractures in community dwelling elderly women unselected for osteoporosis-results of a double blind, placebo controlled randomised study. J Bone Miner Res 22:135–141CrossRef McCloskey EV, Beneton M, Charlesworth D, Kayan K, Detakats D, Dey A, OrgeeJ, Ashford R, Forster M, Cliffe J, Kersh L, Brazier J, Nichol J, Aropuu S, Jalava T, Kanis JA (2006) Clodronate reduces the incidence of fractures in community dwelling elderly women unselected for osteoporosis-results of a double blind, placebo controlled randomised study. J Bone Miner Res 22:135–141CrossRef
30.
Zurück zum Zitat Jones G, Nguyen TV, Sambrook PN, Kelly PJ, Gilbert C, Eisman JA (1994) Symptomatic fracture incidence in elderly men and women. The Dubbo Osteoporosis Epidemiology Study DOES. Osteoporosis Int 4:277–282CrossRef Jones G, Nguyen TV, Sambrook PN, Kelly PJ, Gilbert C, Eisman JA (1994) Symptomatic fracture incidence in elderly men and women. The Dubbo Osteoporosis Epidemiology Study DOES. Osteoporosis Int 4:277–282CrossRef
31.
Zurück zum Zitat Svanborg A (1977) 70 year old people in Gothenburg. A population study in an industrialised Swedish city ii. Journal Presentation of Social and Medical Conditions. Acta Medica Scand 611(suppl):5 Svanborg A (1977) 70 year old people in Gothenburg. A population study in an industrialised Swedish city ii. Journal Presentation of Social and Medical Conditions. Acta Medica Scand 611(suppl):5
32.
Zurück zum Zitat Johansson C, Black D, Johnell O, Oden A, Mellstrom D (1998) Bone mineral density is a predictor of survival. Calcif Tissue Int 63:190–196PubMedCrossRef Johansson C, Black D, Johnell O, Oden A, Mellstrom D (1998) Bone mineral density is a predictor of survival. Calcif Tissue Int 63:190–196PubMedCrossRef
33.
Zurück zum Zitat Fujiwara S, Kagasi F, Masunari N, Naito K, Suzuki G, Fukunage M (2003) Fracture prediction from bone mineral density in Japanese Men and Women. J Bone Min Res 18:1547–1553CrossRef Fujiwara S, Kagasi F, Masunari N, Naito K, Suzuki G, Fukunage M (2003) Fracture prediction from bone mineral density in Japanese Men and Women. J Bone Min Res 18:1547–1553CrossRef
34.
Zurück zum Zitat Fujiwara S, Kasagi F, Yamada M, Kodama K (1997) Risk factors for hip fracture in Japanese cohort. J Bone Min Res 12:998–1004CrossRef Fujiwara S, Kasagi F, Yamada M, Kodama K (1997) Risk factors for hip fracture in Japanese cohort. J Bone Min Res 12:998–1004CrossRef
35.
Zurück zum Zitat Schott AM, Cormier C, Hans D, Favier F, Hausherr E, Dargent-Molina P, Delmas P, Ribot C, Sebert JL, Breart G, Meunier PJ (1998) How hip and whole-body bone mineral density predict hi fracture in elderly women: the EPIDOS Prospective Study. Osteoporos Int 8:247–254PubMedCrossRef Schott AM, Cormier C, Hans D, Favier F, Hausherr E, Dargent-Molina P, Delmas P, Ribot C, Sebert JL, Breart G, Meunier PJ (1998) How hip and whole-body bone mineral density predict hi fracture in elderly women: the EPIDOS Prospective Study. Osteoporos Int 8:247–254PubMedCrossRef
36.
Zurück zum Zitat Bagger YZ, Riis BJ, Alexandersen P, Tanko LB, Christiansen C (2001) Risk factors for development of osteoporosis and cardiovascular disease in postmenopausal Danish women: the PERF study. J Bone Miner Res 16:396 Bagger YZ, Riis BJ, Alexandersen P, Tanko LB, Christiansen C (2001) Risk factors for development of osteoporosis and cardiovascular disease in postmenopausal Danish women: the PERF study. J Bone Miner Res 16:396
37.
Zurück zum Zitat Walley T, Mantgani A (1997) The UK general practice research database. Lancet 350:1097–1099PubMedCrossRef Walley T, Mantgani A (1997) The UK general practice research database. Lancet 350:1097–1099PubMedCrossRef
38.
Zurück zum Zitat Gluer CC, Eastell R, Reid DM, Felsenberg D, Roux C, Barkmann R, Timm W, Bleak T, Almbrecht G, Stewart A, Clowes J, Thomasins FE, Kolta S (2004) Association of five quantitative ultrasound devices and bone densitometry with osteoporotic fractures in a population-based source : the OPUS study. J Bone Miner Res 19:782–793PubMedCrossRef Gluer CC, Eastell R, Reid DM, Felsenberg D, Roux C, Barkmann R, Timm W, Bleak T, Almbrecht G, Stewart A, Clowes J, Thomasins FE, Kolta S (2004) Association of five quantitative ultrasound devices and bone densitometry with osteoporotic fractures in a population-based source : the OPUS study. J Bone Miner Res 19:782–793PubMedCrossRef
39.
Zurück zum Zitat Birks YF, Porthouse J, Addie C, Loughey K, Saxon L, Baverstock M, Francis RM, Reid DM, Watt I, Torgerson DJ (2004) Randomised controlled trial of hip protectors among women living in the Community. Osteoporosis Int 15:701–706CrossRef Birks YF, Porthouse J, Addie C, Loughey K, Saxon L, Baverstock M, Francis RM, Reid DM, Watt I, Torgerson DJ (2004) Randomised controlled trial of hip protectors among women living in the Community. Osteoporosis Int 15:701–706CrossRef
40.
Zurück zum Zitat Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767–773PubMedCrossRef Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767–773PubMedCrossRef
41.
Zurück zum Zitat Sanders KM, Pasco JA, Ugoni A, Nicholson GC, Seeman E, Martin TJ, Skovic B, Panahi S, Kotowicz MA (1998) The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community. The Geelong Osteoporosis Study. J Bone Miner Res 13:1337–1342PubMedCrossRef Sanders KM, Pasco JA, Ugoni A, Nicholson GC, Seeman E, Martin TJ, Skovic B, Panahi S, Kotowicz MA (1998) The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community. The Geelong Osteoporosis Study. J Bone Miner Res 13:1337–1342PubMedCrossRef
42.
Zurück zum Zitat Yoshimura N, Takijiri T, Kinoshita H, Danjoh S, Kasamatsu I, Morioka S, Sakato K, Hashimoto T, Takeshita T (2004) Characteristics and cause of bone mineral densities among fast bone losers in a rural Japanese community: the Miyama study. Osteoporos Int 15:139–144PubMedCrossRef Yoshimura N, Takijiri T, Kinoshita H, Danjoh S, Kasamatsu I, Morioka S, Sakato K, Hashimoto T, Takeshita T (2004) Characteristics and cause of bone mineral densities among fast bone losers in a rural Japanese community: the Miyama study. Osteoporos Int 15:139–144PubMedCrossRef
43.
Zurück zum Zitat Krieg MA, Cornuz J, Ruffieux C, Burckhardt P (2004) Role des ultrasous osseux pour la prediction de fracture de la hauche chez la femme agees 70 ans ou plus: resultants de l’etude SEMOF et comparaison avec les donnees de la literature. Rev Med Suisse Rom 124:59–62PubMed Krieg MA, Cornuz J, Ruffieux C, Burckhardt P (2004) Role des ultrasous osseux pour la prediction de fracture de la hauche chez la femme agees 70 ans ou plus: resultants de l’etude SEMOF et comparaison avec les donnees de la literature. Rev Med Suisse Rom 124:59–62PubMed
44.
Zurück zum Zitat Hayes J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allan C, Rossouw JE (2003) The Women’s Health Initiative recruitment methods and results. Ann Epidemiol 13:S18–S77CrossRef Hayes J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allan C, Rossouw JE (2003) The Women’s Health Initiative recruitment methods and results. Ann Epidemiol 13:S18–S77CrossRef
45.
Zurück zum Zitat Anderson GL, Manson J, Wallace R, Lund B, Hall D, Dairi S, Shumcker S, Wong C-Y, Stein E, Prentice RL (2003) Implementation of the women’s health initiative study design. Ann Epidemiol 13:S5–S17PubMedCrossRef Anderson GL, Manson J, Wallace R, Lund B, Hall D, Dairi S, Shumcker S, Wong C-Y, Stein E, Prentice RL (2003) Implementation of the women’s health initiative study design. Ann Epidemiol 13:S5–S17PubMedCrossRef
46.
Zurück zum Zitat Kanis JA, Oden A, Johnell O, Jonsson B, De Laet C, Dawson A (2002) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporosis Int 12:417–424CrossRef Kanis JA, Oden A, Johnell O, Jonsson B, De Laet C, Dawson A (2002) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporosis Int 12:417–424CrossRef
47.
Zurück zum Zitat Edgeworth FY (1905) The law of error. Proc Cambr Philosoph Soc 20:36 Edgeworth FY (1905) The law of error. Proc Cambr Philosoph Soc 20:36
48.
Zurück zum Zitat Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560PubMedCrossRef Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560PubMedCrossRef
49.
Zurück zum Zitat Van der Klift M, De Laet C, McCloskey EV et al (2004) Risk factors for incident vertebral deformity in men and women: the Rotterdam study. J Bone Miner Res 19:1172–1180PubMedCrossRef Van der Klift M, De Laet C, McCloskey EV et al (2004) Risk factors for incident vertebral deformity in men and women: the Rotterdam study. J Bone Miner Res 19:1172–1180PubMedCrossRef
50.
Zurück zum Zitat Lunt M, Felsenberg D, Reeve J et al (1997) Bone density variation and its effects on risk of vertebral deformity in men and women studied in 13 European centres: the EVOS study. J Bone Miner Res 12:1883–1894PubMedCrossRef Lunt M, Felsenberg D, Reeve J et al (1997) Bone density variation and its effects on risk of vertebral deformity in men and women studied in 13 European centres: the EVOS study. J Bone Miner Res 12:1883–1894PubMedCrossRef
51.
Zurück zum Zitat Silman A, O’Neill T, Cooper C et al (1997) Influence of physical activity on vertebral deformity in men and women: results from the European Vertebral Osteoporosis Study. J Bone Miner Res 12:813–819PubMedCrossRef Silman A, O’Neill T, Cooper C et al (1997) Influence of physical activity on vertebral deformity in men and women: results from the European Vertebral Osteoporosis Study. J Bone Miner Res 12:813–819PubMedCrossRef
52.
Zurück zum Zitat Nevitt MC, Cummings SR, Stone KL et al (1997) Risk factors for a first incident radiographic vertebral fracture in women ≥ years of age: The Study of Osteoporotic fractures Nevitt MC, Cummings SR, Stone KL et al (1997) Risk factors for a first incident radiographic vertebral fracture in women ≥ years of age: The Study of Osteoporotic fractures
53.
Zurück zum Zitat Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 312:1254–1259 Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 312:1254–1259
54.
Zurück zum Zitat Kanis JA, Johnell O (2004) Requirements for DXA for the management of osteoporosis in Europe. Osteoporosis Int 16:229–238CrossRef Kanis JA, Johnell O (2004) Requirements for DXA for the management of osteoporosis in Europe. Osteoporosis Int 16:229–238CrossRef
55.
Zurück zum Zitat Kanis J, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2002) Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30:251–258PubMedCrossRef Kanis J, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2002) Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30:251–258PubMedCrossRef
56.
Zurück zum Zitat Burger H, de Laet CE, Weel AE, Hofman A, Pols HA (1999) Added value of bone mineral density in hip fracture risk scores. Bone 25:369–374PubMedCrossRef Burger H, de Laet CE, Weel AE, Hofman A, Pols HA (1999) Added value of bone mineral density in hip fracture risk scores. Bone 25:369–374PubMedCrossRef
57.
Zurück zum Zitat Black DM, Steinbuch M, Palermo L, Dargent MP, Lindsay R, Hoseyni MS et al (2001) An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12:519–528PubMedCrossRef Black DM, Steinbuch M, Palermo L, Dargent MP, Lindsay R, Hoseyni MS et al (2001) An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12:519–528PubMedCrossRef
58.
Zurück zum Zitat Albrand G, Munoz F, Sornay RE, Duboeuf F, Delmas PD (2001) Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY Study. Bone 32:78–85CrossRef Albrand G, Munoz F, Sornay RE, Duboeuf F, Delmas PD (2001) Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY Study. Bone 32:78–85CrossRef
59.
Zurück zum Zitat Carroll J, Testa M, Erat K, LeBoff M, Fuleihan G-EH (1997) Modelling fracture risk using bone density, age, and years since menopause. Am J Prev Med 13:447–452PubMed Carroll J, Testa M, Erat K, LeBoff M, Fuleihan G-EH (1997) Modelling fracture risk using bone density, age, and years since menopause. Am J Prev Med 13:447–452PubMed
60.
Zurück zum Zitat Dargent-Molina P, Douchin MN, Cormier C, Meunier PJ, Bréart G (2002) Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study. Osteoporos Int 13:593–599PubMedCrossRef Dargent-Molina P, Douchin MN, Cormier C, Meunier PJ, Bréart G (2002) Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study. Osteoporos Int 13:593–599PubMedCrossRef
61.
Zurück zum Zitat Girman CJ, Chandler JM, Zimmerman S, I, Allison R, Hawkes W, Hebel JR et al (2002) Prediction of fracture in nursing home residents. J Am Geriatr Soc 50:1341–1347PubMedCrossRef Girman CJ, Chandler JM, Zimmerman S, I, Allison R, Hawkes W, Hebel JR et al (2002) Prediction of fracture in nursing home residents. J Am Geriatr Soc 50:1341–1347PubMedCrossRef
62.
Zurück zum Zitat Honkanen RJ, Honkanen K, Kroger H, Alhava E, Tuppurainen M, Saarikoski S (2000) Risk factors for perimenopausal distal forearm fractures. Osteoporos Int 11:265–270PubMedCrossRef Honkanen RJ, Honkanen K, Kroger H, Alhava E, Tuppurainen M, Saarikoski S (2000) Risk factors for perimenopausal distal forearm fractures. Osteoporos Int 11:265–270PubMedCrossRef
63.
Zurück zum Zitat Leslie WD, Metge C, Salamon EA, Yuen CK (2002) Bone mineral density testing in healthy postmenopausal women. The role of clinical risk factor assessment in determining fracture risk. J Clin Densitom 5:117–130PubMedCrossRef Leslie WD, Metge C, Salamon EA, Yuen CK (2002) Bone mineral density testing in healthy postmenopausal women. The role of clinical risk factor assessment in determining fracture risk. J Clin Densitom 5:117–130PubMedCrossRef
64.
Zurück zum Zitat Miller PD, Barles S, Brenneman SK, Abbott TA, Ya T, Barrett CE et al (2004) An approach to identifying osteopenic women at increased short-term risk of fracture. Arch Int Med 164:1113–1120CrossRef Miller PD, Barles S, Brenneman SK, Abbott TA, Ya T, Barrett CE et al (2004) An approach to identifying osteopenic women at increased short-term risk of fracture. Arch Int Med 164:1113–1120CrossRef
65.
Zurück zum Zitat Westfall G, Littlefield R, Heaton A, Martin S (2001) Methodology for identifying patients at high risk for osteoporotic fracture. Clin Ther 23:1570–1588PubMedCrossRef Westfall G, Littlefield R, Heaton A, Martin S (2001) Methodology for identifying patients at high risk for osteoporotic fracture. Clin Ther 23:1570–1588PubMedCrossRef
66.
Zurück zum Zitat Colón-Emeric CS, Pieper CF, Artz MB (2002) Can historical and functional risk factors be used to predict fractures in community-dwelling older adults? Development and validation of a clinical tool. Osteoporos Int 13:955–961PubMedCrossRef Colón-Emeric CS, Pieper CF, Artz MB (2002) Can historical and functional risk factors be used to predict fractures in community-dwelling older adults? Development and validation of a clinical tool. Osteoporos Int 13:955–961PubMedCrossRef
67.
Zurück zum Zitat Van Staa T-P, Geusens P, Pols HAP, De Laet C, Leufkens HCM, Cooper C (2005) A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. Q J Med 98:191–198 Van Staa T-P, Geusens P, Pols HAP, De Laet C, Leufkens HCM, Cooper C (2005) A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. Q J Med 98:191–198
68.
Zurück zum Zitat van Staa TP, Leufkens H-GM, Cooper C (2002) Utility of medical and drug history in fracture risk prediction among men and women. Bone 31:508–514PubMedCrossRef van Staa TP, Leufkens H-GM, Cooper C (2002) Utility of medical and drug history in fracture risk prediction among men and women. Bone 31:508–514PubMedCrossRef
69.
Zurück zum Zitat McGrother CW, Donaldson M-MK, Clayton D, Abrams KR, Clarke M (2002) Evaluation of a hip fracture risk score for assessing elderly women: the Melton Osteoporotic Fracture (MOF) study. Osteoporos Int 13:89–96PubMedCrossRef McGrother CW, Donaldson M-MK, Clayton D, Abrams KR, Clarke M (2002) Evaluation of a hip fracture risk score for assessing elderly women: the Melton Osteoporotic Fracture (MOF) study. Osteoporos Int 13:89–96PubMedCrossRef
70.
Zurück zum Zitat Walter LC, Lui LY, Eng C, Covinsky KE (2003) Risk of hip fracture in disabled community-living older adults. J Am Geriatr Soc 51:50–55PubMedCrossRef Walter LC, Lui LY, Eng C, Covinsky KE (2003) Risk of hip fracture in disabled community-living older adults. J Am Geriatr Soc 51:50–55PubMedCrossRef
71.
Zurück zum Zitat McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY, Hip Intervention Program Study Group (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333–340PubMedCrossRef McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY, Hip Intervention Program Study Group (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333–340PubMedCrossRef
72.
Zurück zum Zitat Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Maliee MP, Czachur M, Daifotis AG (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-induced Osteoporosis Intervention Study Group. N Engl J Med 339:292–299PubMedCrossRef Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Maliee MP, Czachur M, Daifotis AG (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-induced Osteoporosis Intervention Study Group. N Engl J Med 339:292–299PubMedCrossRef
73.
Zurück zum Zitat Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, Lane NE, Kaufman JM, Poubelle PE, Hawkins F, Correa-Rotter R, Menkes CJ, Rodriguez-Portales JA, Schnitzer TJ, Block JA, Wing J, McIlwain J III, Westhovens R, Brown J, Melo-Gomes JA, Gruber BL, Yanover MJ, Leite MO, Sammoski KG, Nevitt MC, Sharp JT, Malice MP, Dumortier T, Czachur M, Carofano W, Daifotis A (2001) Two year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomised, double-blind, placebo-controlled extension trial. Arthritis Rheum 44:202–211PubMedCrossRef Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, Lane NE, Kaufman JM, Poubelle PE, Hawkins F, Correa-Rotter R, Menkes CJ, Rodriguez-Portales JA, Schnitzer TJ, Block JA, Wing J, McIlwain J III, Westhovens R, Brown J, Melo-Gomes JA, Gruber BL, Yanover MJ, Leite MO, Sammoski KG, Nevitt MC, Sharp JT, Malice MP, Dumortier T, Czachur M, Carofano W, Daifotis A (2001) Two year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomised, double-blind, placebo-controlled extension trial. Arthritis Rheum 44:202–211PubMedCrossRef
74.
Zurück zum Zitat Reginster JY, Minne HW, Sorensen OH et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (VERT) study group. Osteoporos Int 11:83–91PubMedCrossRef Reginster JY, Minne HW, Sorensen OH et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (VERT) study group. Osteoporos Int 11:83–91PubMedCrossRef
75.
Zurück zum Zitat Kanis JA, Barton I, Johnell O (2005) Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int 16:475–482CrossRef Kanis JA, Barton I, Johnell O (2005) Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int 16:475–482CrossRef
76.
Zurück zum Zitat McCloskey EV, Selby P, Davies M et al (2004) Clodronate reduces vertebral fracture risk in women with post-menopausal or secondary osteoporosis: results of a double blind placebo-controlled 3 year study. J Bone Miner Res 19:728–736PubMedCrossRef McCloskey EV, Selby P, Davies M et al (2004) Clodronate reduces vertebral fracture risk in women with post-menopausal or secondary osteoporosis: results of a double blind placebo-controlled 3 year study. J Bone Miner Res 19:728–736PubMedCrossRef
77.
Zurück zum Zitat Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawieki A, Tulassay Z, Luisetto G, Padrino JM, Doyle D, Prince R, Fardellone P, Sorensen OH, Meunier PJ (2006) Vertebral fracture risk reduction with strontium ranelate in women with post-menopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res, in press Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawieki A, Tulassay Z, Luisetto G, Padrino JM, Doyle D, Prince R, Fardellone P, Sorensen OH, Meunier PJ (2006) Vertebral fracture risk reduction with strontium ranelate in women with post-menopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res, in press
78.
Zurück zum Zitat Marcus R, Wang O, Satterwhite J et al (2003) The skeletal response to teriparatide is largely independent of age, initial bone mineral density and prevalent vertebral fractures in postmenopausal women with osteoporosis. J Bone Miner Res 18:18–23PubMedCrossRef Marcus R, Wang O, Satterwhite J et al (2003) The skeletal response to teriparatide is largely independent of age, initial bone mineral density and prevalent vertebral fractures in postmenopausal women with osteoporosis. J Bone Miner Res 18:18–23PubMedCrossRef
79.
Zurück zum Zitat Johnell O, Kanis JA, Black DM et al (2004) Association between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) study. J Bone Miner Res 19:764–772PubMedCrossRef Johnell O, Kanis JA, Black DM et al (2004) Association between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) study. J Bone Miner Res 19:764–772PubMedCrossRef
Metadaten
Titel
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
verfasst von
J. A. Kanis
A. Oden
O. Johnell
H. Johansson
C. De Laet
J. Brown
P. Burckhardt
C. Cooper
C. Christiansen
S. Cummings
J. A. Eisman
S. Fujiwara
C. Glüer
D. Goltzman
D. Hans
M.-A. Krieg
A. La Croix
E. McCloskey
D. Mellstrom
L. J. Melton III
H. Pols
J. Reeve
K. Sanders
A-M. Schott
A. Silman
D. Torgerson
T. van Staa
N. B. Watts
N. Yoshimura
Publikationsdatum
01.08.2007
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 8/2007
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-007-0343-y

Weitere Artikel der Ausgabe 8/2007

Osteoporosis International 8/2007 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.